# DECITABINE
> **ANDA215355** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD VI · Approved 2024-05-10
## Drug
- **FDA Application Number:** ANDA215355
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DECITABINE
- **Generic name:** DECITABINE
- **Active ingredients:** DECITABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD VI
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2024-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215355)
---
*MORVS · CC0 1.0*